These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 15080167)

  • 1. [Hormone replacement therapy does not prevent coronary heart disease and is associated with increased overall risk for health of postmenopausal women. Final results of studies on hormone replacement therapy efficacy in frame of Women's Health Initiative and data from other recent studies].
    Gratsianskiĭ NA
    Kardiologiia; 2003; 43(9):77-9. PubMed ID: 15080167
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparative review of the risks and benefits of hormone replacement therapy regimens.
    Warren MP
    Am J Obstet Gynecol; 2004 Apr; 190(4):1141-67. PubMed ID: 15118656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Where are we with postmenopausal hormone therapy in 2005?
    Lam PM; Chung TK; Haines C
    Gynecol Endocrinol; 2005 Nov; 21(5):248-56. PubMed ID: 16373243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone therapy for younger postmenopausal women: how can we make sense out of the evidence?
    Salpeter S
    Climacteric; 2005 Dec; 8(4):307-10. PubMed ID: 16390764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.
    Gurney EP; Nachtigall MJ; Nachtigall LE; Naftolin F
    J Steroid Biochem Mol Biol; 2014 Jul; 142():4-11. PubMed ID: 24172877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health risks after cessation of postmenopausal hormone therapy.
    Pines A; Sturdee D; Birkhäuser M;
    Climacteric; 2008 Jun; 11(3):179-80. PubMed ID: 18568782
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk of cardiovascular disease in relation to the use of combined postmenopausal hormone therapy: detection bias and resolution of discrepant findings in two Women's Health Initiative studies.
    Shapiro S
    Climacteric; 2006 Dec; 9(6):416-20. PubMed ID: 17085373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
    Banks E; Canfell K
    Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postmenopausal hormone replacement therapy in the light of the women's health initiative trial.
    van der Mooren MJ; Kenemans P
    Eur J Obstet Gynecol Reprod Biol; 2003 Apr; 107(2):123-4. PubMed ID: 12648855
    [No Abstract]   [Full Text] [Related]  

  • 10. [After the early termination of the Women's Health Initiative study. New American recommendations for postmenopausal hormone therapy].
    Stjernquist M;
    Lakartidningen; 2003 May; 100(20):1790-7. PubMed ID: 12806859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone therapy: the next chapter. Is it time to rewrite the book on postmenopausal hormone use?
    Harv Womens Health Watch; 2011 Mar; 18(7):1-3. PubMed ID: 21526525
    [No Abstract]   [Full Text] [Related]  

  • 12. Weighing the risks and benefits of hormone therapy.
    Toth S; Blanchard E; Herman L; Larson L; Léger MM; McNellis R; Quigley T; Van Dyke E
    JAAPA; 2003 Jun; 16(6):45-7. PubMed ID: 14968505
    [No Abstract]   [Full Text] [Related]  

  • 13. Hormones, menopause, and heart disease: making sense of the Women's Health Initiative.
    Derry PS
    Womens Health Issues; 2004; 14(6):212-9. PubMed ID: 15589771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent epidemiological evidence relevant to the clinical management of the menopause.
    Shapiro S
    Climacteric; 2007 Oct; 10 Suppl 2():2-15. PubMed ID: 17882666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Women's Health Initiative study: perspectives and implications for clinical practice.
    Hammond CB
    Rev Endocr Metab Disord; 2005 May; 6(2):93-9. PubMed ID: 15843880
    [No Abstract]   [Full Text] [Related]  

  • 16. Coronary heart disease and menopause management: the swinging pendulum of HRT.
    Stevenson JC; Hodis HN; Pickar JH; Lobo RA
    Atherosclerosis; 2009 Dec; 207(2):336-40. PubMed ID: 19560146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perspectives on hormone replacement therapy: the Women's Health Initiative and new observational studies sampling the overall population.
    Tannen RL; Weiner MG; Xie D; Barnhart K
    Fertil Steril; 2008 Aug; 90(2):258-64. PubMed ID: 18672122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Timing of hormone therapy influences breast cancer risk.
    Harv Womens Health Watch; 2011 Apr; 18(8):7. PubMed ID: 21544975
    [No Abstract]   [Full Text] [Related]  

  • 19. Hormone replacement therapy: short-term versus long-term use.
    Rousseau ME
    J Midwifery Womens Health; 2002; 47(6):461-70. PubMed ID: 12484668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A personal initiative for women's health: to challenge the Women's Health Initiative.
    Genazzani AR; Gambacciani M
    Gynecol Endocrinol; 2002 Aug; 16(4):255-7. PubMed ID: 12396552
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.